In-Vitro Diagnostics Instruments Market By Product Type (Immunochemistry, Clinical microbiology, POCT, SMBG, Tissue Diagnostics, Molecular Diagnostics, Hemostasis) By End-User and Region - Global Forecast to 2026
17 October 2017
The global in-vitro diagnostics instruments market report, offers in-depth insights, revenue details, and other vital information regarding in vitro diagnostics instruments and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global in vitro diagnostics instruments market, and their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global in-vitro diagnostics instruments market was valued at US$ 7,316.9 Mn in 2016 and is projected to reach US$ 13,881.5 Mn in 2026 at a CAGR of 6.6% from 2017 to 2026.
In-vitro diagnostics (IVD) instruments help in detection of various diseases, conditions, infections, and determination health condition of individuals. These instruments are intended for use in sample collection and examination of specimens taken from the patients. The Food and Drug Administration (FDA) includes in-vitro diagnostics instruments into Class I, II, or III according to the level of regulatory control, which is required to reassure safety and effectiveness of the products. The Code of Federal Regulations lists the classification of existing IVD instruments in 21 CFR 862, 21 CFR 864, and 21 CFR 866.
Key factor driving growth of the global in-vitro diagnostics instruments market is rising demand for personalized medicines, which helps in identification and detection of infections and diseases in individuals. Another factor supporting growth of the target market is increasing demand for minimization of healthcare expenditures. IVD provides automated diagnostic platforms that facilitates real-time and rapid results. Furthermore, increasing point-of-care testing methods that enables medical diagnostic testing at or near the patient is expected to support growth of the global market. However, lack of reimbursement policies in developing economies and stringent regulatory framework is hampering growth of the target market.
The global in-vitro diagnostics instruments market report has been segmented on the basis of product type, end user, and region. On the basis of product type, the global market is segmented into immunochemistry, clinical microbiology, POCT, SMBG, tissue diagnostics, molecular diagnostics, hematology, and hemostasis. On the basis of region, the global market is segmented into The Americas, Europe, Asia Pacific, and Rest of the World.
The market in The Americas is expected to account for highest market share in terms of revenue owing to technological advancement and presence of appropriate healthcare infrastructure in the region. The market in Europe holds the second highest share in terms of revenue owing to advancements in diagnostics technology and increasing heath awareness among individuals regarding diagnosis and prognosis of diseases.
Global market segmentation by product type:
- Clinical microbiology
- Tissue diagnostics
- Molecular diagnostics
Global market segmentation by end user:
- Hospitals and diagnostic laboratories
- Home care
- Academic and research institutes
Global market segmentation by region:
- Asia Pacific
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens AG
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Alere Inc.
- BioMérieux SA
- Becton, Dickinson and Co.
1.0 Chapter 1
2.0 Chapter 2
2.1 Report Description
2.1.1 Market Definition and Scope
Request for Customization
Don't just take our word. We are trusted by these great companies!